Hong Yu sold $600k of HRGN
PRESIDENT at Harvard Apparatus Regenerative Technology, Inc.. 83,676 shares at an average of $7.17, traded Dec 7, 2022, filed Dec 9, 2022.
Score components
- +20RolePresident
- +19Trade size$600k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-22-012348, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | XIn-the-money exercise Common Stockindirect: The spouse of the reporting person | +300,000 | $2.00 | $600k | 306,135 | Dec 9, 2022 |
| Dec 7, 2022 | SOpen-market sale Common Stockindirect: The spouse of the reporting person | -83,676 | $7.17 | $600k | 222,459 | Dec 9, 2022 |
| Dec 7, 2022 | XIn-the-money exercise Warrants (right to buy)derivativeindirect: The spouse of the reporting person | -300,000 | $0.00 | $0 | 0 | Dec 9, 2022 |
Related signals
Other insiders at Harvard Apparatus Regenerative Technology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $394k 368,630 shares | +38% | |
| 38Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $5,100 3,000 shares | +1% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $594 300 shares | +0% | |
| 38Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $21k 11,225 shares | +4% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,966 4,050 shares | +2% | |
| 20Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,598 2,299 shares | +1% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $17k 5,101 shares | +2% | |
| 23Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $4,480 1,600 shares | +1% | |
| 29Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $13k 2,700 shares | +1% | |
| 24Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $4,428 900 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.